Related Experiment Video
Updated: Apr 18, 2026

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry
Published on: November 21, 2025
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Ryuji Hamamoto1, Vassiliki Saloura1, Yusuke Nakamura1
1Section of Hematology/Oncology, Department of Medicine, The University of Chicago, 5841 S. Maryland Avenue, MC 2115 Chicago, Illinois 60637, USA.
Abstract:
Several protein lysine methyltransferases and demethylases have been identified to have critical roles in histone modification. A large body of evidence has indicated that their dysregulation is involved in the development and progression of various diseases, including cancer, and these enzymes are now considered to be potential therapeutic targets. Although most studies have focused on histone methylation, many reports have revealed that these enzymes also regulate the methylation dynamics of non-histone proteins such as p53, RB1 and STAT3 (signal transducer and activator of transcription 3), which have important roles in human tumorigenesis. In this Review, we summarize the molecular functions of protein lysine methylation and its involvement in human cancer, with a particular focus on lysine methylation of non-histone proteins.
Insights
Protein lysine methylation and demethylation are crucial in cancer. This review highlights how these enzymes regulate non-histone proteins, offering new therapeutic targets for cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Protein lysine methylation is a key epigenetic modification.
- Dysregulation of lysine methyltransferases and demethylases is implicated in various diseases, notably cancer.
- These enzymes are emerging as significant therapeutic targets.
Purpose of the Study:
- To review the molecular functions of protein lysine methylation.
- To explore the role of protein lysine methylation in human cancer.
- To emphasize the regulation of non-histone protein methylation in tumorigenesis.
Main Methods:
- Literature review of studies on protein lysine methylation.
- Analysis of the roles of methyltransferases and demethylases.
- Focus on non-histone protein targets.
Main Results:
- Lysine methylation regulates critical cellular processes.
- Aberrant methylation of non-histone proteins like p53, RB1, and STAT3 contributes to cancer development.
- These enzymes offer potential for targeted cancer therapies.
Conclusions:
- Protein lysine methylation is vital in cancer biology.
- Targeting lysine methylation of non-histone proteins presents a promising avenue for cancer treatment.
- Further research into these enzymes could lead to novel therapeutic strategies.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

